Full Text Journal Articles by
Author Shahrokh F Shariat

Advertisement

Find full text journal articles






Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant.

Mike Wenzel, Christoph Würnschimmel, Francesco Chierigo, Zhe Tian, Shahrokh F Shariat, Carlo Terrone, Fred Saad, Derya Tilki, Markus Graefen, Severiné Banek, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz,

<h4>Background</h4>To analyze postoperative, in-hospital, complication rates in patients with organ transplantation before radical prostatectomy (RP).<h4>Methods</h4>From National Inpatient Sample (NIS) database (2000-2015) prostate cancer patients treated with RP were abstracted and stratified according to prior organ transplant versus nontransplant. Multivariable logistic regression models predicted in-hospital complications.<h4>Results</h4>Of all eligible 202,419 RP patients, ... Read more >>

Prostate (The Prostate)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study.

Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, Mike Wenzel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Paolo Verze, Ciro Imbimbo, Alberto Briganti, Vincenzo Mirone, Pierre I Karakiewicz,

<h4>Objectives</h4>To examine the effect of specific Asian ethnic subgroups on stage at presentation and cancer-specific mortality in non-metastatic upper tract urothelial carcinoma among North American upper tract urothelial carcinoma Asian patients treated with radical nephroureterectomy.<h4>Methods</h4>We relied on the Surveillance, Epidemiology and End Results database, from 2004 to 2016. Kaplan-Meier plots ... Read more >>

Int J Urol (International journal of urology : official journal of the Japanese Urological Association)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients.

Benedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, Benedikt Horlemann, Gabriele Sorce, Francesco Chierigo, Zhe Tian, Fred Saad, Markus Graefen, Michele Gallucci, Alberto Briganti, Carlo Terrone, Shahrokh F Shariat, Derya Tilki, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz,

<h4>Introduction</h4>Over the last decade, multiple clinical trials demonstrated improved survival after chemotherapy for metastatic prostate cancer (mPCa). However, real-world data validating this effect within large-scale epidemiological data sets are scarce. We addressed this void.<h4>Materials and methods</h4>Men with de novo mPCa were identified and systemic chemotherapy status was ascertained within the ... Read more >>

Prostate (The Prostate)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma.

Mike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, Luigi Nocera, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Derya Tilki, Severine Banek, Luis A Kluth, Frederik C Roos, Felix K H Chun, Pierre I Karakiewicz,

<h4>Purpose</h4>To compare Cancer-specific mortality (CSM) in patients with Squamous cell carcinoma (SCC) vs. non-SCC penile cancer, since survival outcomes may differ between histological subtypes.<h4>Methods</h4>Within the Surveillance, Epidemiology and End Results database (2004-2016), penile cancer patients of all stages were identified. Temporal trend analyses, cumulative incidence and Kaplan-Meier plots, multivariable Cox ... Read more >>

Cancer Causes Control (Cancer causes & control : CCC)
[2021, :]

Cited: 0 times

View full text PDF listing >>



European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

Marko Babjuk, Maximilian Burger, Otakar Capoun, Daniel Cohen, Eva M Compérat, José L Dominguez Escrig, Paolo Gontero, Fredrik Liedberg, Alexandra Masson-Lecomte, A Hugh Mostafid, Joan Palou, Bas W G van Rhijn, Morgan Rouprêt, Shahrokh F Shariat, Thomas Seisen, Viktor Soukup, Richard J Sylvester,

<h4>Context</h4>The European Association of Urology (EAU) has released an updated version of the guidelines on non-muscle-invasive bladder cancer (NMIBC).<h4>Objective</h4>To present the 2021 EAU guidelines on NMIBC.<h4>Evidence acquisition</h4>A broad and comprehensive scoping exercise covering all areas of the NMIBC guidelines since the 2020 version was performed. Databases covered by the search ... Read more >>

Eur Urol (European urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.

Reza Sari Motlagh, Mohammad Abufaraj, Pierre I Karakiewicz, Pawel Rajwa, Keiichiro Mori, Dong-Ho Mun, Shahrokh F Shariat,

<h4>Purpose</h4>Androgen-regulated enzymes such as the angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease 2 (TMPRSS2) are involved in the SARS-CoV-2 infection process. The expression of TMPRSS2 and its fusion gene, which are increased in the epithelium of the human prostate gland during prostate carcinogenesis, are regulated by androgens. Our ... Read more >>

World J Urol (World journal of urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle-Invasive Bladder Cancer.

David D'Andrea, Peter C Black, Homayoun Zargar, Colin P Dinney, Francesco Soria, Michael S Cookson, Jeffrey S Montgomery, Wassim Kassouf, Marc A Dall'Era, Srikala S Sridhar, John S McGrath, Jonathan L Wright, Andrew C Thorpe, Jeff M Holzbeierlein, Diego M Carrión, Ettore Di Trapani, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat, Kamran Zargar-Shoshtar, Laura S Mertens, Adrian S Fairey, Maria C Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J Campain, Jo-An Seah, Cesar E Ercole, Simon Horenblas, Jonathan Aning, Todd M Morgan, Jay B Shah, Marco Moschini,

<h4>Purpose</h4>To investigate the pathologic response rates and survival associated with 3 versus 4 cycles of cisplatin-based NAC in patients with cT2-4N0M0 MIBC.<h4>Material and methods</h4>In this cohort study we analyzed clinical data of 828 patients treated with NAC and RC between 2000 and 2020<b>.</b> A total of 384 and 444 patients ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002190]

Cited: 0 times

View full text PDF listing >>



The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy.

Luigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Giorgio Gandaglia, Nicola Fossati, Felix K H Chun, Vincenzo Mirone, Markus Graefen, Fred Saad, Shahrokh F Shariat, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz,

<h4>Background</h4>Race/ethnicity may predispose to less favorable prostate cancer characteristics in intermediate risk prostate cancer (IR PCa) patients. We tested this hypothesis in a subgroup of IR PCa patients treated with radical prostatectomy (RP).<h4>Methods</h4>We relied on the Surveillance, Epidemiology and End Results 2004-2016. The effect of race/ethnicity was tested in univariable ... Read more >>

World J Urol (World journal of urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.

Keiichiro Mori, Victor M Schuettfort, Satoshi Katayama, Ekaterina Laukhtina, Benjamin Pradere, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Nico C Grossmann, Pawel Rajwa, Frederik König, Abdulmajeed Aydh, Francesco Soria, Marco Moschini, Pierre I Karakiewicz, Yair Lotan, Douglas Scherr, Martin Haydter, Peter Nyirady, Jeremy Y C Teoh, Shin Egawa, Eva Compérat, Shahrokh F Shariat,

<h4>Background</h4>Elevated preoperative plasma levels of the angiogenesis-related marker VEGF have been associated with worse oncological outcomes in various malignancies.<h4>Objective</h4>To investigate the predictive/prognostic role of VEGF in patients with urothelial carcinoma of the bladder (UCB) treated with radical cystectomy (RC).<h4>Design, setting, and participants</h4>VEGF plasma levels were measured preoperatively in 1036 patients ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis.

Mike Wenzel, Marina Deuker, Luigi Nocera, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Derya Tilki, Markus Graefen, Luis A Kluth, Andreas Becker, Frederik C Roos, Felix K H Chun, Pierre I Karakiewicz,

<h4>Background</h4>The efficacy of tyrosine kinase inhibitor (TKI)-based therapy after previous immuno-oncology therapy (IO) failure has been addressed before. However, summary efficacy estimates have never been generated in these reports. We addressed this void.<h4>Material and methods</h4>We systematically examined TKI efficacy after IO-failure and generated weighted median progression-free survival (PFS) estimates for ... Read more >>

Eur J Cancer (European journal of cancer (Oxford, England : 1990))
[2021, 155:245-255]

Cited: 0 times

View full text PDF listing >>



Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.

Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, ,

<h4>Background</h4>Literature lacks clear evidence regarding the optimal treatment for non-muscle-invasive micropapillary bladder cancer (MPBC) due to its rarity and the presence of only small sample size and single-centre studies.<h4>Objective</h4>To assess cancer-specific mortality (CSM) and overall mortality (OM) between immediate radical cystectomy (RC) and conservative management among T1 high-grade (HG) MPBC.<h4>Design, ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.

David D'Andrea, Peter C Black, Homayoun Zargar, Kamran Zargar-Shoshtari, Francesco Soria, Adrian S Fairey, Laura S Mertens, Colin P Dinney, Maria C Mir, Laura-Maria Krabbe, Michael S Cookson, Niels-Erik Jacobsen, Jeffrey S Montgomery, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Nicholas J Campain, Wassim Kassouf, Marc A Dall'Era, Jo-An Seah, Cesar E Ercole, Simon Horenblas, Srikala S Sridhar, John S McGrath, Jonathan Aning, Jonathan L Wright, Andrew C Thorpe, Todd M Morgan, Jeff M Holzbeierlein, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Jay B Shah, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat,

<h4>Purpose</h4>To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).<h4>Materials and methods</h4>We analyzed data from 1105 patients with MIBC. Patients age was evaluated as continuous variable and stratified in quartiles. Pathologic objective response (pOR; ypT0-Ta-Tis-T1N0) and pathologic complete response (pCR; ypT0N0), ... Read more >>

World J Urol (World journal of urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis.

Ekaterina Laukhtina, Fahad Quhal, Keiichiro Mori, Reza Sari Motlagh, Benjamin Pradere, Victor M Schuettfort, Hadi Mostafaei, Satoshi Katayama, Nico С Grossmann, Pawel Rajwa, Irene Resch, Dmitry Enikeev, Pierre I Karakiewicz, Shahrokh F Shariat, Manuela Schmidinger,

<h4>Purpose</h4>Tyrosine kinase inhibitors (TKIs) have been widely used in the management of patients with metastatic renal cell carcinoma (RCC). However, the use of systemic therapies in the adjuvant setting of localized and locally advanced RCC has shown conflicting results across the literature. Therefore, we aimed to conduct an updated systematic ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries.

Mike Wenzel, Claudia Collà Ruvolo, Luigi Nocera, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Markus Graefen, Andreas Becker, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz,

<h4>Background</h4>Intermediate risk (IR) prostate cancer (PCa) is a highly heterogeneous entity and can be distinguished into favorable and unfavorable IR PCa according to biopsy, PSA and cT-stage characteristics. These differences may translate into differences in treatment type.<h4>Methods</h4>We tested for differences in PCa tumor characteristics and differences in active treatment rates ... Read more >>

Cancer Epidemiol (Cancer epidemiology)
[2021, 74:101994]

Cited: 0 times

View full text PDF listing >>



The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials.

Reza Sari Motlagh, Mohammad Abufaraj, Keiichiro Mori, Abdulmajeed Aydh, Pawel Rajwa, Satoshi Katayama, Nico C Grossmann, Ekaterina Laukhtina, Hadi Mostafai, Benjamin Pradere, Fahad Quhal, Pierre I Karakiewicz, Dmitry V Enikeev, Shahrokh F Shariat,

<h4>Context</h4>Degarelix is associated with high rates of injection site reaction. The US Food and Drug Administration approved relugolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of advanced prostate cancer patients.<h4>Objective</h4>This systematic review and network meta-analysis aimed to compare the efficacy and safety of relugolix versus degarelix.<h4>Evidence acquisition</h4>A systematic ... Read more >>

Eur Urol Oncol (European urology oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.

Benjamin Pradere, David D'Andrea, Victor M Schuettfort, Beat Foerster, Fahad Quhal, Keiichiro Mori, Mohammad Abufaraj, Vitaly Margulis, Marine Deuker, Alberto Briganti, Tim Muilwijk, Kees Hendricksen, Yair Lotan, Pierre Karakiewic, Shahrokh F Shariat, ,

<h4>Purpose</h4>The accurate selection of patients who are most likely to benefit from neoadjuvant chemotherapy is an important challenge in oncology. Serum AGR has been found to be associated with oncological outcomes in various malignancies. We assessed the association of pre-therapy serum albumin-to-globulin ratio (AGR) with pathologic response and oncological outcomes ... Read more >>

World J Urol (World journal of urology)
[2021, 39(7):2567-2577]

Cited: 1 time

View full text PDF listing >>



Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response.

Bernhard Grubmüller, Victoria Jahrreiss, Stephan Brönimann, Fahad Quhal, Keiichiro Mori, Axel Heidenreich, Alberto Briganti, Derya Tilki, Shahrokh F Shariat,

A valid treatment option for recurrence after definite radiotherapy (RT) for localized prostate cancer (PC) is salvage radical prostatectomy (SRP). However, data on SRP are scarce, possibly resulting in an underutilization. A systematic review was performed using MEDLINE (Pubmed), Embase, and Web of Science databases including studies published between January ... Read more >>

Curr Oncol (Current oncology (Toronto, Ont.))
[2021, 28(4):2881-2892]

Cited: 0 times

View full text PDF listing >>



Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy.

Mike Wenzel, Christoph Würnschimmel, Francesco Chierigo, Rocco Simone Flammia, Zhe Tian, Shahrokh F Shariat, Michele Gallucci, Carlo Terrone, Fred Saad, Derya Tilki, Markus Graefen, Andreas Becker, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz,

<h4>Background</h4>Some high-risk prostate cancer (PCa) patients may show more favorable Gleason pattern at radical prostatectomy (RP) than at biopsy.<h4>Objective</h4>To test whether downgrading could be predicted accurately.<h4>Design, setting, and participants</h4>Within the Surveillance, Epidemiology and End Results database (2010-2016), 6690 National Comprehensive Cancer Network (NCCN) high-risk PCa patients were identified.<h4>Outcome measurements and ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The effect of race on stage at presentation and survival in upper tract urothelial carcinoma.

Claudia Collà Ruvolo, Mike Wenzel, Luigi Nocera, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Nicola Longo, Ciro Imbimbo, Alberto Briganti, Vincenzo Mirone, Pierre I Karakiewicz,

Background The effect of racial/ethnic group on survival in upper tract urothelial carcinoma (UTUC) is unknown. We tested this concept in non-metastatic UTUC patients treated with radical nephroureterectomy (RNU) and hypothesized that important differences may exist according to racial/ethnic groups. Material and Methods We relied on the Surveillance Epidemiology and ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis.

Keiichiro Mori, Fahad Quhal, Satoshi Katayama, Hadi Mostafaei, Ekaterina Laukhtina, Victor M Schuettfort, Reza Sari Motlagh, Nico C Grossmann, Pawel Rajwa, Guillaume Ploussard, Alberto Briganti, Takahiro Kimura, Shin Egawa, Rocco Papalia, Diego M Carrion, Cristian Fiori, Shahrokh F Shariat, Francesco Esperto, Benjamin Pradere,

<h4>Introduction</h4>The management of non-metastatic castration-resistant prostate cancer (nmCRPC) has undergone a paradigm shift with the development of androgen receptor axis-targeted (ARAT) agents. The updated results with final overall survival (OS) data of the phase III PROSPER, SPARTAN, and ARAMIS trials have recently been reported. Therefore, we performed an updated meta-analysis ... Read more >>

Minerva Urol Nephrol (Minerva urology and nephrology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients.

Mike Wenzel, Christoph Würnschimmel, Francesco Chierigo, Zhe Tian, Shahrokh F Shariat, Carlo Terrone, Fred Saad, Derya Tilki, Markus Graefen, Frederik C Roos, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz,

<h4>Background</h4>Number of positive prostate biopsy cores represents a key determinant between high versus very high-risk prostate cancer (PCa). We performed a critical appraisal of the association between the number of positive prostate biopsy cores and CSM in high versus very high-risk PCa.<h4>Methods</h4>Within Surveillance, Epidemiology, and End Results database (2010-2016), 13,836 ... Read more >>

Prostate (The Prostate)
[2021, 81(14):1055-1063]

Cited: 0 times

View full text PDF listing >>



Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19.

Dmitry Enikeev, Mark Taratkin, Sergey Efetov, Alexandra Shlomina, Margarita Boldyreva, Irina Galkina, Leonid Spivak, Evgeniy Gitel, Agunda Kuchieva, Vasiliy Mikhailov, Jeremy Yuen-Chun Teoh, Thomas R W Herrmann, Željko Kikic, Viktor Fomin, Shahrokh F Shariat, Petr Glybochko,

<h4>Purpose of review</h4>To investigate the possible effects of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) on kidney function and assess the rate of viral ribonucleic acid (RNA) shedding/detection in urine.<h4>Recent findings</h4>Most of the research on the topic suggests that for the moment our ability to estimate whether SARS-CoV-2 is a ... Read more >>

Curr Opin Urol (Current opinion in urology)
[2021, 31(4):363-368]

Cited: 0 times

View full text PDF listing >>



Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2.

Kristin Zimmermann, Hadi Mostafaei, Axel Heidenreich, Hans U Schmelz, Shahrokh F Shariat, Keiichiro Mori,

<h4>Purpose of review</h4>Several instruments have been designed to evaluate health-related quality of life (HRQoL) in patients with bladder cancer (BC). However, they vary in purpose, domains, and quality. To identify QoL instruments that have been validated for BC patients and to critically assess their domains and limitations.<h4>Recent findings</h4>Of the 11 ... Read more >>

Curr Opin Urol (Current opinion in urology)
[2021, 31(4):304-314]

Cited: 0 times

View full text PDF listing >>



The prognostic value of sarcopenia in patients with prostate cancer: a systematic review.

Victoria Jahrreiss, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat,

<h4>Purpose of review</h4>Sarcopenia is known to affect perioperative and oncologic outcomes in patients with different urological malignancies. Nevertheless, the use of pretreatment sarcopenia as a predictor of clinical outcomes in patients with prostate cancer is still poorly studied. Therefore, we aimed to conduct a systematic review summarizing the available evidence ... Read more >>

Curr Opin Urol (Current opinion in urology)
[2021, 31(4):315-323]

Cited: 0 times

View full text PDF listing >>



Artificial intelligence in prostate histopathology: where are we in 2021?

André Oszwald, Gabriel Wasinger, Benjamin Pradere, Shahrokh F Shariat, Eva M Compérat,

<h4>Purpose of review</h4>Artificial intelligence has made an entrance into mainstream applications of daily life but the clinical deployment of artificial intelligence-supported histological analysis is still at infancy. Recent years have seen a surge in technological advance regarding the use of artificial intelligence in pathology, in particular in the diagnosis of ... Read more >>

Curr Opin Urol (Current opinion in urology)
[2021, 31(4):430-435]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

1.1211 s